Get started
T2 Biosystems, Inc.T2 Biosystems, Inc.T2 Biosystems, Inc.

T2 Biosystems, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

TTOO chart


Full chart

TTOO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.14 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−9.2851 USD
Net income (FY)
‪−50.08 M‬ USD
Revenue (FY)
‪7.19 M‬ USD
Shares float
‪6.02 M‬
Beta (1Y)
−0.65

Employees


Employees (FY)
113
Change (1Y)
−45 −28.48%
Revenue / Employee (1Y)
‪63.65 K‬ USD
Net income / Employee (1Y)
‪−443.16 K‬ USD

About T2 Biosystems, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
John J. Sperzel
Website
t2biosystems.com
Headquarters
Lexington
Founded
2006
FIGI
BBG001J26L54
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

TTOO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TTOO is 0.5799 USD — it has decreased by −18.52% in the past 24 hours. Watch T2 Biosystems, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange T2 Biosystems, Inc. stocks are traded under the ticker TTOO.
TTOO stock has fallen by −33.80% compared to the previous week, the month change is a −63.76% fall, over the last year T2 Biosystems, Inc. has showed a −89.44% decrease.
TTOO reached its all-time high on Aug 21, 2014 with the price of 122,500.0000 USD, and its all-time low was 0.5574 USD and was reached on Nov 8, 2024. View more price dynamics on TTOO chart.
See other stocks reaching their highest and lowest prices.
TTOO stock is 29.06% volatile and has beta coefficient of −0.65. Track T2 Biosystems, Inc. stock price on the chart and check out the list of the most volatile stocks — is T2 Biosystems, Inc. there?
Today T2 Biosystems, Inc. has the market capitalization of ‪10.14 M‬, it has decreased by −24.60% over the last week.
Yes, you can track T2 Biosystems, Inc. financials in yearly and quarterly reports right on TradingView.
T2 Biosystems, Inc. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
TTOO earnings for the last quarter are −0.66 USD per share, whereas the estimation was −0.97 USD resulting in a 31.96% surprise. The estimated earnings for the next quarter are −0.64 USD per share. See more details about T2 Biosystems, Inc. earnings.
T2 Biosystems, Inc. revenue for the last quarter amounts to ‪1.95 M‬ USD, despite the estimated figure of ‪2.10 M‬ USD. In the next quarter, revenue is expected to reach ‪2.85 M‬ USD.
TTOO net income for the last quarter is ‪−8.96 M‬ USD, while the quarter before that showed ‪−13.53 M‬ USD of net income which accounts for 33.77% change. Track more T2 Biosystems, Inc. financial stats to get the full picture.
No, TTOO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 113.00 employees. See our rating of the largest employees — is T2 Biosystems, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. T2 Biosystems, Inc. EBITDA is ‪−42.13 M‬ USD, and current EBITDA margin is −643.60%. See more stats in T2 Biosystems, Inc. financial statements.
Like other stocks, TTOO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade T2 Biosystems, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So T2 Biosystems, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating T2 Biosystems, Inc. stock shows the sell signal. See more of T2 Biosystems, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.